Raytheon critical munitions output jumps more than 90% before next phase of missile expansion

Raytheon increased output across its critical munitions by more than 90% year-on-year during the first nine months of 2026, RTX management said, without identifying individual programmes or missile quantities. Improved material receipts and factory productivity supported the increase, while four multiyear agreements covering Tomahawk, AMRAAM, SM-6 and SM-3 IB underpin further expansion. Management valued those agreements at approximately $70 billion combined and described planned production increases of two to four times existing rates. Tooling, test equipment and supplier investment will continue over the next two to three years, with full-rate output across the portfolio targeted for 2030.